Showing results (41-50 of 168) with videos related to

Sort By:
Pageof 17
Breast Cancer (Tokyo, Japan)|October 9, 2021
6q deletion is frequent but unrelated to patient prognosis in breast cancerPatrick Lebok, Hannah Bönte, Martina Kluth, et al.
Eclinicalmedicine|September 23, 2022
Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept studyChia-Jung Busch, Anna Sophie Hoffmann, Daniele Viarisio, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
Histopathology|July 17, 2013
MALDI imaging on large-scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancerAlexander Quaas, Ahmad Soliaman Bahar, Katharina von Loga, et al.
Endocrine Pathology|March 8, 2020
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine CarcinomasChristoph Fraune, Ronald Simon, Claudia Hube-Magg, et al.
Genes, Chromosomes & Cancer|January 10, 2019
5q21 deletion is often heterogeneous in prostate cancerMartina Kluth, Zaid Al Kilani, Cansu Özden, et al.
World Journal of Surgical Oncology|June 15, 2020
Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinomaTill Eichenauer, Navid Shadanpour, Martina Kluth, et al.
Oncotarget|August 22, 2015
Genomic deletion of chromosome 12p is an independent prognostic marker in prostate cancerMartina Kluth, Ramin Ahrary, Claudia Hube-Magg, et al.
Genes, Chromosomes & Cancer|June 21, 2018
13q deletion is linked to an adverse phenotype and poor prognosis in prostate cancerMartina Kluth, Sekander Scherzai, Franziska Büschek, et al.
The Prostate|July 7, 2020
Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancerSarah Bonk, Martina Kluth, Kristina Jansen, et al.
Pageof 17